PULSION Medical Systems SE
PULSION Medical Systems SE engages in the development, production, and distribution of monitoring, diagnostic, and therapy control systems for recording physiological parameters of hospitalized, seriously ill, and intensive care patients. Its technologies include the PiCCO2 platform, a system used in intensive care medicine for the treatment of critically ill patients; PulsioFlex, which offers te… Read more
PULSION Medical Systems SE (PUS) - Cash Flow Conversion Efficiency
Latest cash flow conversion efficiency as of December 2017: 0.160x
Based on the latest financial reports, PULSION Medical Systems SE (PUS) has a cash flow conversion efficiency ratio of 0.160x as of December 2017.
Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (€3.30 Million) by net assets (€20.60 Million). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations.
PULSION Medical Systems SE - Cash Flow Conversion Efficiency Trend (2003–2017)
This chart illustrates how PULSION Medical Systems SE's cash flow conversion efficiency has evolved over time, based on yearly financial data. Explore and compare other companies by cash flow conversion efficiency.
PULSION Medical Systems SE Competitors by Cash Flow Conversion Efficiency
The table below lists competitors of PULSION Medical Systems SE ranked by their cash flow conversion efficiency.
| Company | Cash Flow Conversion Efficiency |
|---|---|
|
RiverBank Holding Company
PINK:RBNK
|
N/A |
|
EFG INTL N (E2S.SG)
STU:E2S
|
N/A |
|
Premier Foods PLC
LSE:PFD
|
0.024x |
|
NTT DATA - Dusseldorf Stock Exchang
DU:NT5
|
0.052x |
|
Rathdowney Resources Ltd
PINK:RATHF
|
0.013x |
|
TOBA Investments Equities
CO:TOIEQT
|
N/A |
|
DTE Energy Co Pref Series E
NYSE:DTW
|
0.064x |
|
Nvni Group Limited Warrants
NASDAQ:NVNIW
|
0.049x |
Annual Cash Flow Conversion Efficiency for PULSION Medical Systems SE (2003–2017)
The table below shows the annual cash flow conversion efficiency of PULSION Medical Systems SE from 2003 to 2017.
| Year | Net Assets | Operating Cash Flow | Cash Flow Conversion Efficiency | Change |
|---|---|---|---|---|
| 2017-12-31 | €20.60 Million | €3.30 Million | 0.160x | -58.51% |
| 2016-12-31 | €20.60 Million | €7.95 Million | 0.386x | +2.01% |
| 2015-12-31 | €20.60 Million | €7.80 Million | 0.378x | +17.18% |
| 2013-12-31 | €17.59 Million | €5.68 Million | 0.323x | -14.55% |
| 2012-12-31 | €23.84 Million | €9.01 Million | 0.378x | +19.36% |
| 2011-12-31 | €21.10 Million | €6.68 Million | 0.317x | -19.62% |
| 2010-12-31 | €16.56 Million | €6.52 Million | 0.394x | +68.19% |
| 2009-12-31 | €16.98 Million | €3.98 Million | 0.234x | +285.75% |
| 2008-12-31 | €16.24 Million | €986.00K | 0.061x | -77.22% |
| 2007-12-31 | €17.05 Million | €4.55 Million | 0.267x | +21.43% |
| 2006-12-31 | €14.63 Million | €3.21 Million | 0.220x | -24.20% |
| 2005-12-31 | €11.25 Million | €3.26 Million | 0.290x | +20.71% |
| 2004-12-31 | €9.20 Million | €2.21 Million | 0.240x | +139.46% |
| 2003-12-31 | €8.31 Million | €833.00K | 0.100x | -- |